Published in Muscle Nerve on October 01, 1991
Molecular composition of the node of Ranvier: identification of ankyrin-binding cell adhesion molecules neurofascin (mucin+/third FNIII domain-) and NrCAM at nodal axon segments. J Cell Biol (1996) 2.52
Motor neuron disease. J Neurol Neurosurg Psychiatry (1994) 1.78
Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis. Brain Pathol (2010) 1.20
Multifocal motor neuropathy with conduction block: a study of 24 patients. J Neurol Neurosurg Psychiatry (1995) 1.06
Antibodies to heteromeric glycolipid complexes in multifocal motor neuropathy. Eur J Neurol (2012) 0.95
IgM ganglioside GM1 antibodies in patients with autoimmune disease or neuropathy, and controls. J Clin Pathol (1994) 0.92
Antiglycolipid antibodies in peripheral neuropathy: fact or fiction? J Neurol Neurosurg Psychiatry (1994) 0.90
Intravenous immunoglobulin therapy in amyotrophic lateral sclerosis. J Neurol (1996) 0.87
Gangliosides and autoimmune neuropathies: classification and clinical aspects of autoimmune neuropathies. J Neurol Neurosurg Psychiatry (1994) 0.85
Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy. J Neurol Neurosurg Psychiatry (1994) 0.81
Individual Restriction Of Fine Specificity Variability In Anti-GM1 IgG Antibodies Associated With Guillain-Barré Syndrome. Sci Rep (2016) 0.79
Motor conduction block and high titres of anti-GM1 ganglioside antibodies: pathological evidence of a motor neuropathy in a patient with lower motor neuron syndrome. J Neurol Neurosurg Psychiatry (1993) 0.79
Normally occurring human anti-GM1 immunoglobulin M antibodies and the immune response to bacteria. Infect Immun (2004) 0.79
Anti-GM1 antibodies in polyneuropathies of unknown origin. J Clin Pathol (1996) 0.78
Chronic progressive motor polyneuropathy after ganglioside treatment. J Neurol Neurosurg Psychiatry (1994) 0.75
Antiganglioside antibodies in toxic oil syndrome. J Neurol Neurosurg Psychiatry (1995) 0.75
Chlorambucil fails to improve patients with motor neuropathies and antibodies to gangliosides. J Neurol Neurosurg Psychiatry (1992) 0.75
Coupling of nerve growth factor to its receptor: inhibition by anti-GM3 ganglioside antibody. Cell Mol Neurobiol (2001) 0.75